Collective launches Zero Interest Option Exercise Loan Read More

Benchling stock

Benchling Stock


Looking to sell Benchling stock or options?

Contact us
Founded: 2012Funding to Date: $425M
Visit website

Benchling is a developer of a laboratory collaboration platform that aims to expedite and enhance teamwork in life science research. Benchling's platform offers a range of integrated applications that are designed to speed up R&D processes at all stages. This enables scientists to design, share, and document experiments, and share DNA-sequence data via the cloud. As a result, researchers have the necessary resources to speed up, assess, and predict R&D from discovery to bioprocessing, all from a single platform.

Investors include:
Tiger Global Management logo
Benchmark logo
Founders Fund logo
Andreessen Horowitz logo
Sequoia Capital logo
Further Key Investors:

Draper Associates, Rogue Capital, Benchmark (San Francisco), ICONIQ Growth, Rock Health Capital, Elad Gil, Y Combinator, Lone Pine Capital, Ashton Kutcher, Artisanal Ventures, Lux Capital, Spark Capital, Matt Huang, Christopher Golda, Michael Montano, Thrive Capital, Adam Draper, Eight Roads, F-Prime Capital, Collective Liquidity, Foreword, Ensemble Labs, Menlo Ventures, Byers Capital, Alkeon Capital Management.

Collective Representative

Looking to sell Benchling Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you


Management Team

Sajith WickramasekaraCo-Founder, Chief Executive Officer & Board Member
Ashutosh SinghalCo-Founder, President and Board Member
Richard WongChief Financial Officer
Stephen DeasyChief Technology Officer
Zach PowersChief Information Security Officer
Lindsey IrvineChief Marketing Officer
Niall WallChief Partner Officer & Head of Partners
Shawna WolvertonChief Product Officer

Board Members

Ashutosh SinghalBoard Member
Eric VishriaBoard Member
Jennifer GoldsmithBoard Member
Krista Anderson-CoppermanBoard Member
Miles GrimshawBoard Member
Ron GillBoard Member
Sajith WickramasekaraBoard Member
William J.G. GriffithBoard Member

Other HealthTech companies from Collective's Target Portfolio

Maven Clinic stock stock

Companies backed by the same VC's

Alation stock
Apollo  stock
Apollo Graph stock
Attentive stock
BigID stock
Cerebras Systems stock
Chainalysis stock
Chronosphere stock
Clari stock
ClickHouse stock
Cresta stock
Databricks stock
Deel stock
Discord stock
FrontApp stock
Glean stock
Guideline stock
Hugging Face stock
Kong stock
Locus Robotics stock
Maven Clinic stock
Rec Room stock
Replit stock
Rippling stock
Skydio stock
Temporal Technologies stock
Vanta stock
Vendr stock
Verkada stock stock
Whatnot stock
Workato stock

Benchling in the News

Source: PRNewswireAnnouncing Benchling Bioprocess, the End-to-End Solution for Modern, High-throughput Process Development

Benchling Bioprocess delivers new design, planning, and execution capabilities on a unified platform, to address the evolving requirements of modern process development SAN FRANCISCO, Sept. 19, 2023 /PRNewswire/ -- Benchling announced Benchling Bioprocess, a …

Source: PRNewswireBenchling Delivers an Integrated R&D Ecosystem with New Product Offerings

New product features include JMP integration, BLAST, and AlphaFold to drive faster decision-making and better data-driven insights as labs scale their R&D SAN FRANCISCO, June 6, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry…

Source: PRNewswireBenchling Creates Open Source Library of Lab Instrument Data Converters

Benchling partners with Allotrope, backing industry standards and making library of open source industry data converters freely available to the scientific community SAN FRANCISCO, May 16, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnolo…

Source: Yahoo FinanceLife sciences software startup Benchling lays off 9% of workforce

The startup joins a growing number of U.S. firms, including Facebook-parent Meta Platforms Inc, Inc and several startups, to downsize its workforce

Source: PRNewswireBenchling Bolsters Commitment to Security with Type 2 SOC 2

Rigorous examination confirms Benchling offers best-in-class security to protect its global biotech customer base SAN FRANCISCO, Jan. 26, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry, announced it has successfully complete…

Source: PRN NewswireBenchling Announces New Executive Appointments and 1,000 Customer Milestone

Benchling, the R&D Cloud powering the biotechnology industry, announced the appointment of new executive leadership to its engineering and field organizations. These hires come at the same time the company achieved significant financial milestones. In the first half of its fiscal year, Benchling surpassed 1,000 customers and increased subscription revenue 90% year-over-year. Dollar-based net expansion was greater than 150%, indicative of customers rapidly growing their use of the R&D Cloud.